These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 27363508)

  • 1. An Individualized Risk Calculator for Research in Prodromal Psychosis.
    Cannon TD; Yu C; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Heinssen R; Jeffries CD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Kattan MW
    Am J Psychiatry; 2016 Oct; 173(10):980-988. PubMed ID: 27363508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.
    Carrión RE; Cornblatt BA; Burton CZ; Tso IF; Auther AM; Adelsheim S; Calkins R; Carter CS; Niendam T; Sale TG; Taylor SF; McFarlane WR
    Am J Psychiatry; 2016 Oct; 173(10):989-996. PubMed ID: 27363511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator.
    Zhang T; Xu L; Tang Y; Li H; Tang X; Cui H; Wei Y; Wang Y; Hu Q; Liu X; Li C; Lu Z; McCarley RW; Seidman LJ; Wang J;
    Psychol Med; 2019 Sep; 49(12):1990-1998. PubMed ID: 30213278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state.
    Kotlicka-Antczak M; Karbownik MS; Stawiski K; Pawełczyk A; Żurner N; Pawełczyk T; Strzelecki D; Fusar-Poli P
    Eur Psychiatry; 2019 May; 58():72-79. PubMed ID: 30870626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk.
    Perkins DO; Olde Loohuis L; Barbee J; Ford J; Jeffries CD; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Seidman LJ; Tsuang M; Walker EF; Woods SW
    Am J Psychiatry; 2020 Feb; 177(2):155-163. PubMed ID: 31711302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.
    Cannon TD; Cadenhead K; Cornblatt B; Woods SW; Addington J; Walker E; Seidman LJ; Perkins D; Tsuang M; McGlashan T; Heinssen R
    Arch Gen Psychiatry; 2008 Jan; 65(1):28-37. PubMed ID: 18180426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.
    Addington J; Liu L; Perkins DO; Carrion RE; Keefe RS; Woods SW
    Schizophr Bull; 2017 Jan; 43(1):57-63. PubMed ID: 27798225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study.
    Thompson A; Nelson B; Yung A
    Schizophr Res; 2011 Mar; 126(1-3):51-7. PubMed ID: 21035313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program.
    Zhang T; Xu L; Li H; Woodberry KA; Kline ER; Jiang J; Cui H; Tang Y; Tang X; Wei Y; Hui L; Lu Z; Cao L; Li C; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; Wang J
    Psychol Med; 2021 Mar; 51(4):653-660. PubMed ID: 31839016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
    Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
    Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up.
    Brandizzi M; Valmaggia L; Byrne M; Jones C; Iwegbu N; Badger S; McGuire P; Fusar-Poli P
    J Psychiatr Res; 2015 Jun; 65():115-23. PubMed ID: 25837413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.
    Worthington MA; Walker EF; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD
    Schizophr Res; 2021 Jan; 227():95-100. PubMed ID: 33046334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
    Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
    J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Biomarkers of Vulnerability and Progression to Psychosis.
    Cannon TD
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S127-32. PubMed ID: 26656880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    Schizophr Res; 2019 Jun; 208():41-43. PubMed ID: 30745066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.